TREATING LIPIDS FOR PREVENTION OF CAD : HOW AGGRESSIVE SHOULD WE BE? Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration.
1 Dai grandi trial con statine al razionale del target terapeutico del colesterolo in prevenzione secondaria Dr Stefano Bucci UO Cardiologia ASL 3 Difendiamo.
G Lipid Lowering In Ckd
CHOLESTEROL AND OUR LIVES الدهنيات وحياتنا OMAR DHAIMAT,MD FACE Dr. Sulaiman Al-Habib medical Center.
Sudden death Scope of the problem and risk stratification INSERM U970 Cardiovascular epidemiology and sudden death Pr Xavier JOUVEN.
The efFects of Pharmacological management of lipids in patients with CKD Andrew Monson FY1 18/9/14.
The Importance of Potential Statin in High Risk Patient Masrul Syafri Bagian Kardiologi & Kedokteran Vaskular FKUA/RS M Djamil Padang CRE/006/FEB14-FEB15/BR.
The 2009 Canadian Lipid Guidelines Milan Gupta, MD Department of Medicine, McMaster University Division of Cardiology, William Osler Health Centre Division.
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
Disclosures / Conflicts of Interest Alfred K. Cheung, M.D. None relevant to this topic.
Aggressive Lipid Lowering Treatment
Case Study “SK”